These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25684549)

  • 1. Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel.
    Mannikko R; Bridgland-Taylor MH; Pye H; Swallow S; Abi-Gerges N; Morton MJ; Pollard CE
    Br J Pharmacol; 2015 Jun; 172(12):3112-25. PubMed ID: 25684549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
    Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
    J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.
    McPate MJ; Duncan RS; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2005 Aug; 334(2):441-9. PubMed ID: 16011830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological characterization of a small molecule activator on human ether-a-go-go-related gene (hERG) potassium channel.
    Dong X; Liu Y; Niu H; Wang G; Dong L; Zou A; Wang K
    J Pharmacol Sci; 2019 Jul; 140(3):284-290. PubMed ID: 31481348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
    Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
    J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state.
    Johnson JP; Balser JR; Bennett PB
    Biophys J; 1999 Nov; 77(5):2534-41. PubMed ID: 10545354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis.
    Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX
    Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
    Gerlach AC; Stoehr SJ; Castle NA
    Mol Pharmacol; 2010 Jan; 77(1):58-68. PubMed ID: 19805508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and electrophysiological characterization of SKF-32802: A novel hERG agonist found through a large-scale structural similarity search.
    Donovan BT; Bandyopadhyay D; Duraiswami C; Nixon CJ; Townsend CY; Martens SF
    Eur J Pharmacol; 2018 Jan; 818():306-327. PubMed ID: 29050968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6.
    Lu Y; Mahaut-Smith MP; Huang CL; Vandenberg JI
    J Physiol; 2003 Aug; 551(Pt 1):253-62. PubMed ID: 12923204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
    Hancox JC; Levi AJ; Witchel HJ
    Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
    Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
    Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new mexiletine-derived agonist of the hERG K
    Gualdani R; Cavalluzzi MM; Tadini-Buoninsegni F; Lentini G
    Biophys Chem; 2017 Oct; 229():62-67. PubMed ID: 28673509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
    Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
    Drug Des Devel Ther; 2015; 9():867-77. PubMed ID: 25733807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels.
    Perrin MJ; Kuchel PW; Campbell TJ; Vandenberg JI
    Mol Pharmacol; 2008 Nov; 74(5):1443-52. PubMed ID: 18701618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.
    McPate MJ; Duncan RS; Hancox JC; Witchel HJ
    Br J Pharmacol; 2008 Nov; 155(6):957-66. PubMed ID: 18724381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel.
    Männikkö R; Overend G; Perrey C; Gavaghan CL; Valentin JP; Morten J; Armstrong M; Pollard CE
    Br J Pharmacol; 2010 Jan; 159(1):102-14. PubMed ID: 19673885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HERG channels by the local anaesthetic articaine.
    Siebrands CC; Friederich P
    Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.